What are Health Clusters ?
Innovation Super clusters bring together vital stakeholders required to catalyse innovation across a region.
World leading innovation super clusters like Boston (Healthcare), San Francisco (Tech), Tel Aviv (Tech, Healthtech), Singapore (Manufacturing, Healthtech) and London (Fintech) compete on a global stage to attract talent, foreign direct investment (FDI), Capital providers, industry and create a collaborative framework across large ecosystems.
The UK has a deep strength in both the life sciences and research and innovation. Collectively the UK is the third largest cluster behind San Francisco and Boston.
In the UK successful life science clusters bring together industry, investors, academia, the NHS, and organisations such as the National Institute for Health Research (NIHR), and Academic Health Science Networks (AHSNs) and are anchored by institutions including research-intensive NHS Trusts, universities, or manufacturing hubs
Clusters drive growth and productivity by facilitating networking and collaboration; research and innovation; skills development and training; internationalisation of cluster assets and the ability to do ‘high risk’ work in a low-risk environment
The most successful innovation clusters have a formal cluster development organisation to drive place-based development in their given sector. They do this by focussing on assets that are world class and close to scale, acting ambitiously to compete globally in key areas, attracting public and private investment, and backing in those areas to make impact.
HIRANI is a cluster organisation and was established in Northern Ireland in 2019. We provide leadership to align Northern Ireland’s health and life science ecosystem with the life sciences vision regionally and nationally.
We are focused on the high growth potential technology areas of precision diagnostics and data integration, digital health and wearables, and advanced pharmaceutical delivery systems, with particular focus in clinical areas of national significance such as oncology and healthy ageing.
We also work to leverage Northern Ireland’s unique advantages of agility, working across an integrated health and care system, and direct access to both UK and EU markets.
Analysis shows that prior to forming HIRANI, the life science and health sector together supported approximately 100,000 jobs, which is 5 percent of the population of Northern Ireland, and generated £1.1 billion gross value added (GVA) in 2018.
By embedding cluster connectivity, access to investment, and partnering with complimentary expertise in other UK clusters - such as NHSA and Medcity - GVA is likely to double to £2.2 billion.
The major cluster organisation members across the UK are:
Some of the challenges that limit the benefits of the life sciences clusters